MY178049A - Composition with inhibitory effect on viral integrase activity - Google Patents

Composition with inhibitory effect on viral integrase activity

Info

Publication number
MY178049A
MY178049A MYPI2013700282A MYPI2013700282A MY178049A MY 178049 A MY178049 A MY 178049A MY PI2013700282 A MYPI2013700282 A MY PI2013700282A MY PI2013700282 A MYPI2013700282 A MY PI2013700282A MY 178049 A MY178049 A MY 178049A
Authority
MY
Malaysia
Prior art keywords
composition
inhibitory effect
integrase activity
viral integrase
nutraceutical
Prior art date
Application number
MYPI2013700282A
Inventor
Sambanthamurthi Ravigadevi
Yew Ai Tan
Md Ali Jabariah
Saridah Wan Omar Wan
Original Assignee
Malaysian Palm Oil Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Malaysian Palm Oil Board filed Critical Malaysian Palm Oil Board
Priority to MYPI2013700282A priority Critical patent/MY178049A/en
Priority to PCT/MY2014/000019 priority patent/WO2014129884A2/en
Publication of MY178049A publication Critical patent/MY178049A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Present invention relates to a composition comprising extracts from oil palm in preventing and treating viral infection and related diseases. The composition may be provided as compounds with pharmaceutically acceptable carriers, in effective dosage forms of solid, liquid, solution, nutraceutical, nutritional supplementary and suppository form. The composition may be administered orally and by intravenous.
MYPI2013700282A 2013-02-21 2013-02-21 Composition with inhibitory effect on viral integrase activity MY178049A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI2013700282A MY178049A (en) 2013-02-21 2013-02-21 Composition with inhibitory effect on viral integrase activity
PCT/MY2014/000019 WO2014129884A2 (en) 2013-02-21 2014-02-19 Composition with inhibitory effect on viral integrase activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2013700282A MY178049A (en) 2013-02-21 2013-02-21 Composition with inhibitory effect on viral integrase activity

Publications (1)

Publication Number Publication Date
MY178049A true MY178049A (en) 2020-09-30

Family

ID=51391944

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013700282A MY178049A (en) 2013-02-21 2013-02-21 Composition with inhibitory effect on viral integrase activity

Country Status (2)

Country Link
MY (1) MY178049A (en)
WO (1) WO2014129884A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2560710B (en) * 2017-03-17 2021-10-20 Malaysian Palm Oil Board Compositions comprising oil palm phenolics and shikimic acid or derivatives thereof and uses thereof
WO2018165780A1 (en) * 2017-03-17 2018-09-20 Malaysian Palm Oil Board Antioxidant, anti-inflammatory compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY184667A (en) * 2007-07-23 2021-04-15 Malaysian Palm Oil Board An antiviral composition
MY160702A (en) * 2010-06-16 2017-03-15 Malaysian Palm Oil Board Compositions comprising shikimic acid obtained from oil palm based materials and method of producing thereof

Also Published As

Publication number Publication date
WO2014129884A2 (en) 2014-08-28
WO2014129884A3 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
IN2014DN09434A (en)
IN2015DN01156A (en)
CL2015000784A1 (en) Compounds derived from acylaminopyrimidine, interferon inducers; pharmaceutical composition that includes them; its use in the treatment of viral infections, immune disorders, cancer and other diseases.
WO2011113013A3 (en) Methods and compositions for treating viral or virally-induced conditions
MX2022009352A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus.
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA201690687A1 (en) REPLICATION INHIBITORS OF THE VIRUS OF IMMUNODEFICIENCY
PH12015502230B1 (en) Novel viral replication inhibitors
MY181602A (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
PH12017500747B1 (en) Heterocyclic compound
WO2015058664A8 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
MX2022001796A (en) Methods and compositions to inhibit symptoms associated with veisalgia.
SG10201805267UA (en) Piperazine derivatives having multimodal activity against pain
MX2015012455A (en) Method for the treatment of fatty liver disease.
MY178049A (en) Composition with inhibitory effect on viral integrase activity
MD4763B1 (en) Pharmaceutical composition
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
WO2015077693A3 (en) Use of microrna 146-a in the diagnosis, treatment and prevention of picornavirus infection and microran 146-a antagonists
TW201613606A (en) Therapeutic drug for chronic renal failure
BR112014026158A2 (en) methods and compositions for the treatment of viral infections
EA201300096A1 (en) DRUGS WITH ANTIBACTERIAL, CONTRACTING AND IMMUNE MODEL
MY169312A (en) An antiviral pharmaceutical composition
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
WO2014031034A8 (en) Pharmaceutical compositions containing ipidacrine and use thereof to treat potency disorders and other sexual activity disorders